" class="no-js "lang="en-US"> Jan Fagerberg - Medtech Alert
Thursday, March 30, 2023
Jan Fagerberg

Jan Fagerberg

About Jan Fagerberg

Related Story

Enterome Announces First Patient Dosed in a Phase 1/2 Trial with Second OncoMimics™ Vaccine, EO2463, in Non-Hodgkin Lymphoma

July 12 2021

Enterome SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to […]